Nine Masts Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,180,000
Closed -$1.05M 32
2023
Q3
$1.05M Buy
+3,180,000
New +$27.4M 0.75% 17
2019
Q2
Sell
-60,000
Closed -$3K 158
2019
Q1
$3K Sell
60,000
-100,000
-63% -$2.39M ﹤0.01% 167
2018
Q4
$210K Buy
+160,000
New +$3.81M 0.03% 114
2018
Q3
Sell
-1,000
Closed -$58K 306
2018
Q2
$58K Hold
1,000
0.01% 242
2018
Q1
$224K Sell
1,000
-700
-41% -$13K 0.03% 133
2017
Q4
$4K Sell
1,700
-1,000
-37% -$15.9K ﹤0.01% 230
2017
Q3
$200K Buy
+2,700
New +$40.8K 0.03% 83

Other funds holding BHC

Nine Masts Capital's BHC Position: Q3 2024 in Review

Nine Masts Capital sold out of Bausch Health (BHC) in Q3 2024, closing a stake of 183,040 shares — an estimated $1.28M sold.

Nine Masts Capital first reported a position in BHC in Q3 2017 and held it in 9 quarters. The position peaked at $9.28M in Q1 2024. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • Nine Masts Capital reported no remaining Bausch Health position as of Q3 2024 after selling out during the quarter.
  • Nine Masts Capital sold 183,040 Bausch Health shares in Q3 2024, an estimated $1.28M.
  • Nine Masts Capital first reported a position in Bausch Health in Q3 2017 and held it in 9 quarters.
  • Nine Masts Capital's Bausch Health position peaked at $9.28M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Nine Masts Capital's 13F filing for Q3 2024, filed 12 Nov 2024.